Equities

Carmat SA

Carmat SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)1.12
  • Today's Change-0.138 / -10.97%
  • Shares traded30.00
  • 1 Year change-75.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 16:20 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments8.015139
Total Receivables, Net5.153.663.83
Total Inventory241714
Prepaid expenses5.295.244.30
Other current assets, total0.040.040.01
Total current assets427862
Property, plant & equipment, net9.956.706.78
Goodwill, net------
Intangibles, net000.09
Long term investments0.610.740.53
Note receivable - long term------
Other long term assets0.070.000.00
Total assets538569
LIABILITIES
Accounts payable9.616.538.39
Accrued expenses5.935.705.18
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total0.020.010.01
Total current liabilities161214
Total long term debt585552
Total debt585552
Deferred income tax------
Minority interest------
Other liabilities, total6.801.172.53
Total liabilities806968
SHAREHOLDERS EQUITY
Common stock0.990.910.62
Additional paid-in capital9.047085
Retained earnings (accumulated deficit)(55)(69)(99)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total181515
Total equity(27)160.96
Total liabilities & shareholders' equity538569
Total common shares outstanding252316
Treasury shares - common primary issue0.010.010.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.